- Report
- March 2024
- 196 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- November 2023
- 178 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- October 2023
- 171 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- October 2023
- 180 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- June 2023
- 245 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- March 2022
- 273 Pages
Global
From €5062EUR$5,250USD£4,329GBP
- Report
- January 2023
- 155 Pages
United States
From €5736EUR$5,950USD£4,906GBP
- Report
- October 2021
- 112 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- April 2023
- 115 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- June 2022
- 242 Pages
Global
From €3471EUR$3,600USD£2,968GBP
- Report
- July 2022
- 176 Pages
Global
From €5562EUR$5,769USD£4,757GBP
- Report
- November 2023
- 160 Pages
Global
From €2891EUR$2,999USD£2,473GBP
- Book
- February 2024
- 640 Pages
- Book
- October 2023
- 576 Pages
- Book
- January 2023
- 304 Pages
- Book
- May 2014
- 616 Pages
- Book
- July 2012
- 448 Pages
- Book
- October 2010
- 454 Pages
The Cancer Management market within the context of Oncology is a rapidly growing sector of the healthcare industry. It encompasses a wide range of services, products, and technologies that are used to diagnose, treat, and manage cancer. This includes treatments such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, as well as diagnostic tests, imaging, and other supportive care services. The market also includes a variety of products and services related to cancer prevention, such as screening tests, lifestyle modifications, and genetic testing.
The Cancer Management market is driven by advances in technology, increasing prevalence of cancer, and the growing demand for personalized treatments. Additionally, the increasing availability of healthcare services and the rising awareness of cancer among the general population are also contributing to the growth of the market.
Some of the major companies in the Cancer Management market include Roche, Novartis, Merck, Pfizer, Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Show Less Read more